Hospital
Franciscan Health Michigan City
Franciscan Health Michigan City was paid $21.22M by Medicaid between Jan 2018 and Dec 2024, across 138 billing codes. Its largest line is 99284, emergency room visit (serious) — 26% of everything it billed.
33Billing provider infoFRANCISCAN HEALTH MICHIGAN CITY
MICHIGAN CITY, IN 46360
MICHIGAN CITY, IN 46360
33aNPI1710051941assigned 11/20/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$21.22M
24GClaims367,822
24DCodes billed138
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Indiana
Rank by total paid#19 of 69
Median peer was paid$9.76M
This provider vs. median2.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 58,554 | $1.20M | |
| 2019 | 37,060 | $2.09M | |
| 2020 | 31,088 | $1.87M | |
| 2021 | 49,118 | $3.31M | |
| 2022 | 72,548 | $4.88M | |
| 2023 | 74,515 | $4.88M | |
| 2024incomplete | 44,939 | $3.00M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 26% | 36,539 | 30,417 | $5.51M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 23% | 34,851 | 30,626 | $4.88M |
| 71045 | Radiologic examination, chest; single view | 6.2% | 9,163 | 7,785 | $1.31M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3.9% | 5,760 | 4,787 | $830K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3.8% | 13,727 | 9,193 | $799K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 3.6% | 1,095 | 911 | $773K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 3.5% | 10,715 | 9,427 | $733K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 2.7% | 454 | 397 | $563K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 2.2% | 5,968 | 5,330 | $461K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.1% | 2,673 | 2,391 | $436K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 1.9% | 1,978 | 928 | $406K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.8% | 10,894 | 2,832 | $392K |
126 more codes
| J7030 | Infusion, normal saline solution , 1000 cc | 1.5% | 8,101 | $328K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.5% | 7,671 | $321K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.4% | 7,712 | $296K |
| 80053 | Comprehensive metabolic panel | 1.3% | 39,342 | $279K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.1% | 46,598 | $243K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.1% | 10,407 | $230K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 1.1% | 130 | $224K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 1,908 | $192K |
| 41899 | Unlisted procedure, dentoalveolar structures | <1% | 111 | $180K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 432 | $178K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 1,480 | $171K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,120 | $170K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 45 | $123K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,778 | $123K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 1,067 | $111K |
| 36415 | Collection of venous blood by venipuncture | <1% | 31,197 | $96K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 54 | $74K |
| 64493 | <1% | 117 | $51K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,769 | $46K |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 1,449 | $45K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 1,208 | $38K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 189 | $35K |
| 84484 | <1% | 4,143 | $34K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 552 | $30K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 251 | $30K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 503 | $29K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 271 | $29K |
| 97161 | <1% | 383 | $28K | |
| 81001 | <1% | 10,700 | $23K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,061 | $21K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 901 | $20K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 100 | $19K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 686 | $18K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 780 | $18K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 101 | $17K |
| 81025 | <1% | 3,073 | $16K | |
| 64483 | <1% | 17 | $15K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 3,430 | $15K |
| 83690 | <1% | 3,865 | $14K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 3,266 | $14K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 280 | $11K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 493 | $10K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 259 | $10K |
| 99221 | <1% | 32 | $9K | |
| 96523 | <1% | 123 | $9K | |
| 80055 | <1% | 293 | $9K | |
| 83735 | <1% | 1,764 | $9K | |
| 87634 | <1% | 145 | $8K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 65 | $8K |
| 97014 | <1% | 99 | $7K | |
| 64494 | <1% | 82 | $5K | |
| 87430 | <1% | 1,015 | $5K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 27 | $5K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,240 | $5K |
| 76801 | <1% | 27 | $5K | |
| 27096 | <1% | 15 | $5K | |
| 80050 | General health panel | <1% | 28 | $4K |
| 82728 | <1% | 510 | $4K | |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | <1% | 551 | $4K |
| 81003 | <1% | 2,305 | $4K | |
| 83615 | <1% | 605 | $4K | |
| 80061 | Lipid panel | <1% | 472 | $3K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 525 | $3K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 47 | $3K |
| 36591 | <1% | 80 | $3K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 197 | $3K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 83 | $3K |
| 76830 | Ultrasound, transvaginal | <1% | 14 | $2K |
| 83540 | <1% | 501 | $2K | |
| 93017 | <1% | 26 | $2K | |
| 83550 | <1% | 325 | $2K | |
| 84703 | <1% | 330 | $2K | |
| 87081 | <1% | 738 | $2K | |
| 96367 | <1% | 48 | $2K | |
| 82607 | <1% | 145 | $1K | |
| 82746 | <1% | 128 | $1K | |
| 84439 | <1% | 210 | $1K | |
| 83655 | <1% | 81 | $1K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 169 | $974.36 |
| 82077 | <1% | 70 | $884.22 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 174 | $878.19 |
| 85027 | <1% | 222 | $861.58 | |
| 94060 | <1% | 13 | $798.96 | |
| 72110 | <1% | 13 | $734.26 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 81 | $710.63 |
| 84436 | <1% | 115 | $525.39 | |
| 82950 | <1% | 130 | $519.66 | |
| 84702 | <1% | 49 | $463.27 | |
| 85651 | <1% | 106 | $306.71 | |
| 85610 | <1% | 267 | $273.18 | |
| 84146 | <1% | 28 | $264.72 | |
| 82747 | <1% | 14 | $195.16 | |
| 82105 | <1% | 12 | $187.82 | |
| 85379 | <1% | 29 | $181.51 | |
| 86803 | <1% | 13 | $179.92 | |
| 85730 | <1% | 32 | $106.54 | |
| 84550 | <1% | 60 | $100.87 | |
| 87420 | <1% | 14 | $73.71 | |
| 80076 | <1% | 13 | $70.23 | |
| 82248 | <1% | 16 | $43.13 | |
| 85007 | <1% | 21 | $39.81 | |
| 84100 | <1% | 13 | $34.02 | |
| 94729 | <1% | 13 | $13.36 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 356 | $2.40 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 5,049 | $1.01 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 3,926 | $0.70 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 0% | 569 | $0.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 2,427 | $0.00 |
| J0670 | Injection, mepivacaine hydrochloride, per 10 ml | 0% | 349 | $0.00 |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 0% | 551 | $0.00 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 0% | 159 | $0.00 |
| J1644 | Injection, heparin sodium, per 1000 units | 0% | 341 | $0.00 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 98 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 94 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 30 | $0.00 |
| 77002 | 0% | 14 | $0.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 2,721 | $0.00 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 0% | 2,332 | $0.00 |
| 88342 | 0% | 20 | $0.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 54 | $0.00 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 0% | 136 | $0.00 |
| 88304 | 0% | 33 | $0.00 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 0% | 115 | $0.00 |
| 90744 | 0% | 13 | $0.00 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 42 | $0.00 |
| G0010 | Administration of hepatitis b vaccine | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCASSARA, PAMELA (CFO - NORTHERN INDIANA)